Seneb BioSciences, Inc.

Seneb BioSciences, Inc. is an early-stage biopharmaceutical company focused on the development of therapeutics for neurological diseases & orphan drug diseases. The company also offers contract research services in the areas of production, process development and analytical testing of proteins, peptides and small molecules.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttp://www.senebbio.com
Founded2010
Disease Focus
Development Stage
STOCK CODENon Listed
Address
3805 Old Easton Road, PA, 18902
Doylestown
United States
Email
Contact Number
+1 267-893-6571

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”” connections=”true” suffix=””]

Seneb utilizes its proprietary glycolipid technology to develop therapeutics for orphan drug diseases and other neurodegenerative diseases such as Huntingtons Disease and Parkinsons Disease.

In 2015, Senab was awarded $233,804 USD NIH STTR Phase I grant to develope Neurotrophic Agents for the treatment of Parkinsons Disaese. while in 2013, SBIR awarded $314k, for Glycolipid Replacement Therapy for Huntingtons Disease.